alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
NASA LogoNTRSNTRS - NASA Technical Reports ServerSearchmore_vertCollectionsAboutNewsHelpLogin Back to ResultsReducing Aviation Fuel Costs with Non-Destructive TestingThermal barrier coatings (TBCs) are absolutely critical to the efficient and safe operation of gas turbine engines (GTEs). Manufacturing TBCs is a complex chemical, thermal and mechanical process that requires precise control. And yet, the variation in life of a TBC operated within a GTE is large. This variation ultimately reduces operational performance via a designed reduction to the turbine entry temperature, T4.This paper makes the case for developing advanced THz and sub-millimeter based nondestructive testing (NDT) techniques, capable of estimating when TBC components will fail. Such a technique could identify TBCs with low expected remaining useful lifetimes, directly after production. These TBCs could be re-manufactured, thereby not only improving their own expected useful life, but also the mean lifetime of the entire manufacturing population. A series of calculations demonstrates that TBCs with enhanced life characteristics can withstand higher T4 temperatures. Assuming that a GTE is to operate at a constant thrust, this increased temperature can be traded for a reduction in fuel flow. An analysis comparing fuel savings to manufacturing costs shows that substantial savings are achievable.Document ID20190002273Acquisition SourceGlenn Research CenterDocument TypeTechnical Memorandum (TM)AuthorsSchemmel, Peter J.*(NASA Glenn Research Center Cleveland, OH, United States)*Date AcquiredApril 11, 2019Publication DateApril 1, 2019Subject CategoryQuality Assurance And ReliabilityAircraft Propulsion And PowerReport/Patent NumberNASA/TM-2019-220165GRC-E-DAA-TN66898Funding Number(s)WBS: WBS 109492.02.03.02.20.02Distribution LimitsPublicCopyrightWork of the US Gov. Public Use Permitted.Keywordsmicrowavesthermal barrier coatingsNon-destructive testingAvailable DownloadsNameType20190002273.pdfSTIcloud_downloadcontent_copyvisibilityRelated RecordsThere are no records associated with this record.visibility_offNo Preview Available
 No Fear Act | Freedom of Information Act | Office of the Inspector General | Agency Financial ReportsNASA Web Privacy Policy and Important Notices | NASA Guidelines for Quality of InformationDisclaimers, Copyright, Terms of Use | Accessibility | NASA OCIO | USA.gov | NASA.govContact Us | Site MapSTI LogoNASA Official: JoAnne R. Calhoun Site Curator: STI Compliance and Distribution Services Last Modified: September 12, 2024
§ 520.1409 Methylprednisolone and aspirin. ( a ) *Specifications.* Each tablet contains 0.5 milligram of methylprednisolone and 300 milligrams of aspirin.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs* — ( 1 ) *Amount.* Under 15 pounds, 1 ⁄ 4 to 1 tablet daily; 15 to 60 pounds, 1 to 2 tablets daily; 60 pounds and over, 2 tablets daily. Administer total daily dose in divided doses 6 to 10 hours apart, with a light feeding. When response is attained, dosage should be gradually reduced until maintenance level is achieved.
( 2 ) *Indications for use.* As an anti-inflammatory and analgesic agent.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[48 FR 21566, May 13, 1983, as amended at 78 FR 28824, May 20, 2014]
<PAGE>

                                                                    Exhibit 21.1


                              LIST OF SUBSIDIARIES
                              --------------------

<TABLE>
<CAPTION>
                                                            PERCENT OWNED              JURISDICTION
NAME OF SUBSIDIARY                                      DIRECTLY OR INDIRECTLY       OF INCORPORATION
                                                            BY REGISTRANT

ACTIVE
------
<S>                                                             <C>                 <C>
Encre Consumables B.V. (Encre)                                   100%                    Amsterdam
                                                                                        Netherlands
NUR America Inc. (NUR America)                                   100%                  Massachusetts,
                                                                                       United States
NUR Asia Pacific (Hong Kong) Ltd. (NUR Asia Pacific)             100%                 Hong Kong, China
NUR DO Brazil Ltda. (NUR Brazil)                                 100%                 San Paulo, Brazil
NUR Europe S.A. (NUR Europe)                                     100%                 Brussels, Belgium
NUR Hungary Trading and Software Licensing Limited               100%                 Budapest, Hungary
Liability Company (HOC)
NUR Macroprinters (Shanghai) Ltd. (NUR Shanghai)                 100%                  Shanghai, China
NUR Media Solutions S.A. (NUR Media Solutions)                   100%                 Brussels, Belgium

Salsa Digital Printers Ltd. (Salsa Digital Printers)             100%                Texas, United States
Signtech Japan Ltd. (Signtech Japan)                             100%                   Tokyo, Japan
NUR Pro Engineering Ltd.                                          50%                Rosh Ha'ain, Israel
Stillachem S.A. (Stillachem)                                    50.1%                Charleroi, Belgium
</TABLE>





----------------------
38590.

#### CLINE v. THE STATE.

Franicum, Judge.

1. The conviction of the defendant for the offense of possessing non-tax-paid whisky was authorized under evidence that the sheriff, who made a search of the defendant’s dwelling house for intoxicating liquors, “heard the stuff being poured out”; that upon search of the house, the sheriff found a jar on the kitchen sink with a small amount of whisky in it; that no tax stamps were affixed to the jar; and that the sink had an odor of whisky in it. *Corbin v. State,*84 Ga. App. 763 (67 S. E. 2d 478); *McQuire v. State,*82 Ga. App. 132 (60 S. E. 2d 526); *Lacount v. State,*25 Ga. App. 767 (104 S. E. 920). The defendant, in his unsworn statement, denied any knowledge of any whisky in his house, but his statement shows that he moved into the house the day before the sheriff made the search. After the conviction, the defendant filed a motion for a new trial which was overruled by the trial court. Counsel for defendant insists that Chapter 58-10 of the Code does not apply to “dry counties”; that the chapter applies only to those counties where there may be a lawful license issued under *Code Ann.*§ 58-1002. And, therefore, Floyd County being a “dry county,” the conviction of the defendant was not authorized. This contention is without merit. *Code*§ 58-1056 makes the possession of “any distilled spirits or alcohol by any person” a misdemeanor, unless there shall be tax stamps affixed as provided by Chapter 58-10. The general grounds of the motion for a new trial are without merit.

2. The defendant challenged the array of the jurors before *746pleading to the merits of the case, which challenge was overruled by the trial court. He attempts to assign this ruling as error by a special ground of a motion for a new trial. This is not a proper procedural method by which.one may seek a review of such ruling, as a direct assignment of error complaining of such ruling in the bill of exceptions would be necessary. *Porch v. State,*207 Ga. 645 (63 S. E. 2d 902); *Mattox v. State,*181 Ga. 361 (182 S. E. 11); *Hargroves v. State,*179 Ga. 722 (177 S. E. 561); *Lumpkin v. State,*152 Ga. 229 (109 S. E. 664).

Decided November 29, 1960.

*Fullbright & Duffey, Harl C. Duffey, Jr.,*for plaintiff in error.

*Chastine Parker, Solicitor-General, Horace T. Clary, Assistant Solicitor,*contra.

3. The last special ground assigns as error the failure of the trial judge to charge the Code provision as to what type of revenue stamp was required where possession of a container of whisky with no such tax stamps affixed was charged as a crime in order that the jury understand the criminal act. There was no written request for such charge. *Vinson v. State,*102 Ga. App. 327 (116 S. E. 2d 240).

*Judgment affirmed.*

*Townsend, P. J., Carlisle and Jordan, JJ., concur.*
EX-10.1



 Exhibit 10.1 

AMENDMENT #1 TO CONSULTING SERVICES AGREEMENT 

THIS AMENDMENT #1 TO CONSULTING SERVICES AGREEMENT (this “Amendment”) is dated May 1, 2017, and is entered into by
and between Aditya Chatterjee (“Consultant”) and Global Eagle Entertainment Inc., a Delaware corporation (the “Company”). Consultant and the Company shall be referred to, individually, as a “party,”
and, collectively, as the “parties.” 
 The parties entered into a Consulting Agreement effective as of November 12,
2017 (the “Consulting Agreement”) for a six-month term ending on May 12, 2017 (the “Original Termination Date”). The parties hereby agree to amend the “Term” as set forth on the Work Statement
(attached as Exhibit A thereto) to automatically renew for successive one-month period(s) following the Original Termination Date, subject however to earlier termination as set forth in Section 3 of the Consulting Agreement. 

All other provisions of the Consulting Agreement remain in full force and effect in accordance with their terms. 

CONSULTANT 
 Aditya Chatterjee 

 

									
	Signature:	 	/s/ Aditya Chatterjee	 		 	Date:	 	5/1/2017

 COMPANY 
 GLOBAL
EAGLE ENTERTAINMENT INC. 

			
		
	By:	 	/s/ Stephen Ballas
		
	Name:	 	Stephen Ballas
		
	Title:	 	EVP & General Counsel
		
	Date:	 	5-1-2017
Editorial Note on Part 189
Editorial Note: Nomenclature changes to part 189 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 70 FR 40880, July 15, 2005; and 70 FR 67651, Nov. 8, 2005.

§ 189.113 Cinnamyl anthranilate. ( a ) The food additive cinnamyl anthranilate (C16H15NO2, CAS Reg. No. 87-29-6) is the ester of cinnamyl alcohol and anthranilic acid. Cinnamyl anthranilate is a synthetic chemical that has not been identified in natural products at levels detectable by available methodology. It has been used as a flavoring agent in food.
( b ) Food containing any added cinnamyl anthranilate is deemed to be adulterated in violation of the act based upon an order published in the Federal Register of October 23, 1985.
[50 FR 42932, Oct. 23, 1985]
§ 507.60 Circumstances that may lead FDA to withdraw a qualified facility exemption. ( a ) FDA may withdraw a qualified facility exemption under § 507.5(d): ( 1 ) In the event of an active investigation of a foodborne illness outbreak that is directly linked to the qualified facility; or
( 2 ) If FDA determines that it is necessary to protect the public (human or animal) health and prevent or mitigate a foodborne illness outbreak based on conditions or conduct associated with the qualified facility that are material to the safety of the animal food manufactured, processed, packed, or held at such facility.
( b ) Before FDA issues an order to withdraw a qualified facility exemption, FDA: ( 1 ) May consider one or more other actions to protect the public (human or animal) health or mitigate a foodborne illness outbreak, including, a warning letter, recall, administrative detention, suspension of registration, refusal of animal food offered for import, seizure, and injunction;
( 2 ) Must notify the owner, operator, or agent in charge of the facility, in writing of circumstances that may lead FDA to withdraw the exemption, and provide an opportunity for the owner, operator, or agent in charge of the facility to respond in writing, within 15 calendar days of the date of receipt of the notification, to FDA's notification; and
( 3 ) Must consider the actions taken by the facility to address the circumstances that may lead FDA to withdraw the exemption.
<PAGE>



                                                                    Exhibit 21.1


                              LIST OF SUBSIDIARIES


<TABLE>
<CAPTION>
NAME OF SUBSIDIARY                                        PERCENT OWNED
                                                     DIRECTLY OR INDIRECTLY
                                                           BY REGISTRANT
ACTIVE
------
<S>                                                      <C>
Encre Consumables B.V. (Encre)                                  100%

NUR America Inc. (NUR America)                                  100%

NUR Asia Pacific (Hong Kong) Ltd. (NUR Asia Pacific)            100%
NUR DO Brazil Ltda. (NUR Brazil)                                100%
NUR Europe S.A. (NUR Europe)                                    100%
NUR Hungary Trading and Software Licensing Limited              100%
Liability Company (HOC)
NUR Macroprinters (Shangai) Ltd. (NUR Shanghai)                 100%
NUR Media Solutions S.A. (NUR Media Solutions)                  100%

Salsa Digital Printers Ltd. (Salsa Digital Printers)            100%
NUR Japan Ltd. (NUR Japan)                                      100%
NUR Pro Engineering Ltd. (NUR Pro Engineering)                   50%
Stillachem S.A. (Stillachem)                                    100%
</TABLE>
<TABLE> <S> <C>

<ARTICLE>                    5
<PERIOD-TYPE>                 3-MOS       6-MOS
<FISCAL-YEAR-END>            MAY-31-1997  MAY-31-1997
<PERIOD-END>                 NOV-30-1996  NOV-30-1996
<CASH>                             604385      604385
<SECURITIES>                            0           0
<RECEIVABLES>                     2086985     2086985
<ALLOWANCES>                            0           0
<INVENTORY>                       1581219     1581219
<CURRENT-ASSETS>                  4978997     4978997
<PP&E>                            4964903     4964903
<DEPRECIATION>                          0           0
<TOTAL-ASSETS>                   11533993    11533993
<CURRENT-LIABILITIES>             2577539     2577539
<BONDS>                           3078095     3078095
<COMMON>                            14773       14773
<PREFERRED-MANDATORY>                   0           0
<PREFERRED>                             0           0
<OTHER-SE>                        2802934     2802934
<TOTAL-LIABILITY-AND-EQUITY>     11533993    11533993
<SALES>                           6034329    12015731
<TOTAL-REVENUES>                  6034329    12015731
<CGS>                             5074139    10218156
<TOTAL-COSTS>                     6588640    13098518
<OTHER-EXPENSES>                        0           0
<LOSS-PROVISION>                        0           0
<INTEREST-EXPENSE>                 171978      363559
<INCOME-PRETAX>                   (726289)   (1446346)
<INCOME-TAX>                       231000      447000
<INCOME-CONTINUING>               (495289)    (999346)
<DISCONTINUED>                          0           0
<EXTRAORDINARY>                         0           0
<CHANGES>                               0           0
<NET-INCOME>                      (495289)    (999346)
<EPS-PRIMARY>                       (0.33)      (0.67)
<EPS-DILUTED>                       (0.33)      (0.67)

</TABLE>
<PAGE>   1




                                                                   EXHIBIT 23.1



                       CONSENT OF INDEPENDENT ACCOUNTANTS

We consent to the incorporation by reference in the Registration Statement of
Forcenergy Inc on Form S-8, (File No. 33-80919) of our report dated March 20,
1998 on our audits of the consolidated financial statements of Forcenergy Inc as
of December 31, 1997 and 1996, and for the years ended December 31, 1997, 1996
and 1995, which report is included in this Annual Report on Form 10-K.



COOPERS & LYBRANDS L.L.P.


Miami, Florida
March 25, 1998
<PAGE>   1
                          [KELLER ROHRBACK LETTERHEAD]


                                  March 1, 1999

Frontier Financial Corporation
332 S.W. Everett Mall Way
P.O. Box 2215
Everett, WA  98203

        Re: Registration Statement Form S-8 of Shares of
            Common Stock, No Par Value Per Share,
            of Frontier Financial Corporation

Ladies and Gentlemen:

     We have acted as counsel to you in connection with the preparation of a
Registration Statement on Form S-8 (the "Registration Statement") under the
Securities Act of 1933, as amended (the "Act"), which you are filing with the
Securities and Exchange Commission with respect to 10,000 shares of common
stock, no par value per share (the "Shares"), which may be issued pursuant to
the Frontier Financial Corporation 1999 Employee Stock Award Plan (the "Plan").
We have examined the Registration Statement and such documents and records of
the Company and other documents as we have deemed necessary for the purpose of
this opinion. In giving this opinion, we are assuming the authenticity of all
instruments presented to us as originals, the conformity with originals of all
instruments presented to us as copies and the genuineness of all signatures.

     Based upon, and subject to, the foregoing, we are of the opinion that upon
the issuance of the Shares by the Company in accordance with the terms of the
Plan, such Shares will be duly authorized, validly issued, fully paid and
nonassessable.

     We hereby consent to the filing of this opinion as Exhibit 5.1 to the
Registration Statement. In giving such consent, we do not admit that we are in
the category of persons whose consent is required under Section 7 of the Act.

                                        Very truly yours,

                                        /s/


                                        Keller Rohrback, LLP
### Water resources in the vicinity of municipalities on the eastern Mesabi Iron Range and the Vermilion Iron Range, northeastern Minnesota

By: R. D. CotterH. L. YoungL. R. PetriC. H. Prior

                            https://doi.org/10.3133/wsp1759F

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plate:  **Plate 1**                            (pdf)
- NGMDB Index Page:  **National Geologic Map Database Index Page**
- Superseded Publications:
                                        Water resources in the vicinity of municipalities on the Eastern Mesabi Iron Range and the Vermilion Iron Range, northeastern Minnesota(1963)                                    

- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Additional supplies of water are available near the municipalities on the eastern Mesabi Iron Range and the Vermilion Iron Range. On the eastern Mesabi Range the potential for additional development of both ground-water and surface-water supplies are good, and on the Vermilion Range the best potential for development is from surface-water resources.

The most productive aquifers in the area of this report are the Biwabik Iron-Formation and the stratified glacial drift; Bast of Colby Lake the Biwabik Iron-Formation is not an important aquifer, and it is entirely absent on the Vermilion Range. Also, on the Vermilion Range the glacial drift is generally too thin to yield the quantities of water found on the Mesabi Range.

Surface-water supplies in the area of this report are good. An extensive network of river systems and many lakes form a large untapped potential supply. Records of flow from eight gaging stations are presented as are data from many wells and test holes.

Ground water commonly has a high concentration of iron and manganese and is hard. Surface water generally has a high concentration of iron and is colored. Analyses of water from many sources are included.

#### Study Area

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1769a Sodium metasilicate. ( a ) Sodium metasilicate (CAS Reg. No. 6834-92-0) is a strongly alkaline white powder. It does not occur naturally but rather is synthesized by melting sand with sodium carbonate at 1400 °C. The commercially available forms of sodium metasilicate are the anhydrous form (Na2SiO3), the pentahydrate (Na2SiO3·5H2O), and the nonahydrate (Na2SiO3·9H2O).
( b ) The ingredient must be of a purity suitable for its intended use.
( c ) In accordance with § 184.1(b)(1), the ingredient is used in food with no limitation other than current good manufacturing practice. The affirmation of this ingredient as generally recognized as safe (GRAS) as a direct human food ingredient is based upon the following current good manufacturing practice conditions of use: ( 1 ) The ingredient is used as a processing aid as defined in § 170.3(o)(24) of this chapter.
( 2 ) The ingredient is used to treat the following foods at levels not to exceed current good manufacturing practice: for use in washing and lye peeling of fruits, vegetables, and nuts when used in accordance with § 173.315 of this chapter; for use as a denuding agent in tripe; for use as a hog scald agent in removing hair; and for use as a corrosion preventative in canned and bottled water when used in accordance with § 165.110 of this chapter.
( d ) Prior sanctions for this ingredient different from the uses established in this section do not exist or have been waived.
[50 FR 38781, Sept. 25, 1985; 50 FR 42011, Oct. 17, 1985, as amended at 72 FR 10357, Mar. 8, 2007; 73 FR 8608, Feb. 14, 2008]